MedTrace Logo

Oasys vs. Extreme H20 Xtra 59

NCT00477763 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2008-02-18

No results posted yet for this study

Summary

To compare the performance of Oasys to Extreme H20 xtra 59 in dry eye contact lens pts who receive Restasis in 1 eye and vehicle (Endura) in the other eye.

Conditions

  • Dry Eye

Interventions

DRUG

Restasis, Refresh Endura

1. Restasis 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening 2. Refresh Endura 0.4ml- (in the eye) instill twice daily in the randomized eye morning and evening

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • Thomas Kislan, OD · Hazleton Eye Specialists

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-02-29
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00477763 on ClinicalTrials.gov